Canada Life’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.4M | Buy |
121,723
+18,623
| +18% | +$3.43M | 0.04% | 335 |
|
|
2025
Q4 | $18.2M | Sell |
103,100
-32,557
| -24% | -$5.32M | 0.03% | 393 |
|
|
2025
Q3 | $18.8M | Buy |
135,657
+4,724
| +4% | +$639K | 0.03% | 446 |
|
|
2025
Q2 | $16.5M | Buy |
130,933
+5,426
| +4% | +$676K | 0.03% | 459 |
|
|
2025
Q1 | $17.2M | Sell |
125,507
-1,124
| -0.9% | -$161K | 0.03% | 445 |
|
|
2024
Q4 | $19.3M | Sell |
126,631
-3,257
| -3% | -$549K | 0.03% | 418 |
|
|
2024
Q3 | $25.2M | Buy |
129,888
+122
| +0.1% | +$25.5K | 0.04% | 359 |
|
|
2024
Q2 | $30.1M | Buy |
129,766
+4,539
| +4% | +$986K | 0.06% | 307 |
|
|
2024
Q1 | $27M | Sell |
125,227
-20,416
| -14% | -$4.78M | 0.05% | 324 |
|
|
2023
Q4 | $37.5M | Sell |
145,643
-16,518
| -10% | -$4.06M | 0.08% | 244 |
|
|
2023
Q3 | $41.7M | Buy |
162,161
+3,504
| +2% | +$937K | 0.1% | 193 |
|
|
2023
Q2 | $45.4M | Sell |
158,657
-8,053
| -5% | -$2.4M | 0.11% | 187 |
|
|
2023
Q1 | $46.4M | Buy |
166,710
+25,045
| +18% | +$6.93M | 0.12% | 181 |
|
|
2022
Q4 | $39.4M | Sell |
141,665
-8,120
| -5% | -$2.29M | 0.1% | 211 |
|
|
2022
Q3 | $39.9M | Sell |
149,785
-9,797
| -6% | -$2.08M | 0.11% | 191 |
|
|
2022
Q2 | $32.6M | Sell |
159,582
-49,828
| -24% | -$10.2M | 0.09% | 235 |
|
|
2022
Q1 | $46.5M | Sell |
209,410
-3,977
| -2% | -$865K | 0.1% | 220 |
|
|
2021
Q4 | $51.1M | Sell |
213,387
-28,387
| -12% | -$7.3M | 0.11% | 201 |
|
|
2021
Q3 | $68.9M | Sell |
241,774
-161
| -0.1% | -$52.8K | 0.16% | 122 |
|
|
2021
Q2 | $83.8M | Sell |
241,935
-22,759
| -9% | -$6.89M | 0.19% | 105 |
|
|
2021
Q1 | $73.7M | Sell |
264,694
-31,005
| -10% | -$8.36M | 0.18% | 120 |
|
|
2020
Q4 | $72.2M | Sell |
295,699
-12,813
| -4% | -$3.31M | 0.14% | 160 |
|
|
2020
Q3 | $87.5M | Sell |
308,512
-25,605
| -8% | -$7.14M | 0.19% | 121 |
|
|
2020
Q2 | $89.1M | Buy |
334,117
+105,985
| +46% | +$31.9M | 0.2% | 114 |
|
|
2020
Q1 | $72.5M | Buy |
228,132
+10,625
| +5% | +$3.22M | 0.19% | 114 |
|
|
2019
Q4 | $64M | Sell |
217,507
-12,025
| -5% | -$3.34M | 0.14% | 161 |
|
|
2019
Q3 | $53.5M | Sell |
229,532
-5,231
| -2% | -$1.22M | 0.13% | 183 |
|
|
2019
Q2 | $54.9M | Sell |
234,763
-4,496
| -2% | -$1.04M | 0.13% | 177 |
|
|
2019
Q1 | $56.4M | Buy |
239,259
+33,309
| +16% | +$10.5M | 0.15% | 155 |
|
|
2018
Q4 | $58.8M | Buy |
205,950
+18,770
| +10% | +$5.99M | 0.17% | 132 |
|
|
2018
Q3 | $66.2M | Sell |
187,180
-18,704
| -9% | -$6.44M | 0.16% | 147 |
|
|
2018
Q2 | $59.8M | Sell |
205,884
-18,437
| -8% | -$5.18M | 0.14% | 161 |
|
|
2018
Q1 | $61.5M | Buy |
224,321
+11,557
| +5% | +$3.59M | 0.15% | 159 |
|
|
2017
Q4 | $67.7M | Sell |
212,764
-7,352
| -3% | -$2.36M | 0.16% | 143 |
|
|
2017
Q3 | $68.2M | Sell |
220,116
-8,765
| -4% | -$2.6M | 0.17% | 131 |
|
|
2017
Q2 | $62M | Buy |
228,881
+42,001
| +22% | +$11.1M | 0.17% | 135 |
|
|
2017
Q1 | $51.1M | Buy |
186,880
+3,018
| +2% | +$853K | 0.14% | 156 |
|
|
2016
Q4 | $52.3M | Buy |
183,862
+159
| +0.1% | +$47.1K | 0.15% | 154 |
|
|
2016
Q3 | $57.5M | Buy |
183,703
+7,322
| +4% | +$2.17M | 0.17% | 136 |
|
|
2016
Q2 | $42.6M | Buy |
176,381
+32,570
| +23% | +$8.58M | 0.13% | 173 |
|
|
2016
Q1 | $37.4M | Buy |
143,811
+6,370
| +5% | +$1.68M | 0.14% | 169 |
|
|
2015
Q4 | $42.1M | Sell |
137,441
-21,327
| -13% | -$6.13M | 0.16% | 150 |
|
|
2015
Q3 | $46.3M | Sell |
158,768
-19,028
| -11% | -$6.28M | 0.18% | 124 |
|
|
2015
Q2 | $71.7M | Sell |
177,796
-16,101
| -8% | -$6.46M | 0.25% | 91 |
|
|
2015
Q1 | $81.7M | Buy |
193,897
+36,419
| +23% | +$14.4M | 0.28% | 83 |
|
|
2014
Q4 | $53.4M | Sell |
157,478
-2,307
| -1% | -$746K | 0.18% | 135 |
|
|
2014
Q3 | $53M | Sell |
159,785
-6,849
| -4% | -$2.26M | 0.18% | 130 |
|
|
2014
Q2 | $52.4M | Sell |
166,634
-45,451
| -21% | -$13.7M | 0.17% | 134 |
|
|
2014
Q1 | $64.5M | Buy |
212,085
+17,489
| +9% | +$5.55M | 0.23% | 101 |
|
|
2013
Q4 | $54.6M | Sell |
194,596
-40,162
| -17% | -$10.4M | 0.19% | 112 |
|
|
2013
Q3 | $56.5M | Buy |
234,758
+97,084
| +71% | +$21.7M | 0.22% | 102 |
|
|
2013
Q2 | $29.6M | Buy |
+137,674
| New | +$29.4M | 0.19% | 102 |
|
Other funds holding BIIB
VCM
VPM
Canada Life's BIIB Position: Q1 2026 in Review
Canada Life increased its Biogen (BIIB) stake by 18% in Q1 2026, buying an estimated $3.43M and bringing the position to 121,723 shares worth $22.4M. The position accounts for 0.04% of the portfolio, ranked #335.
Canada Life first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $89.1M in Q2 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Canada Life held 121,723 shares of Biogen worth $22.4M as of Q1 2026.
- Canada Life bought 18,623 Biogen shares in Q1 2026, an estimated $3.43M.
- Biogen made up 0.04% of Canada Life's portfolio in Q1 2026, its #335 holding.
- Canada Life first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Canada Life's Biogen position peaked at $89.1M in Q2 2020.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.